Study of Very Brief Exposure for PTSD in Combat Veterans
This study is looking at a new way to help U.S. combat veterans with Post-Traumatic Stress Disorder (PTSD). It's testing something called Very Brief Exposure (VBE), where you briefly see combat images (17 milliseconds) that are then quickly hidden. The goal is to see how VBE and regular viewing of combat images affect your brain activity and feelings of fear. Researchers also want to know how aware you are of the images and if you can tolerate the exposures. You might be able to join if you are a male or female between 18 and 50 years old, have a PTSD diagnosis from a combat experience, and meet certain scores on questionnaires. The study aims to enroll 80 participants, but its current status is unclear.
- Study design
- This is an interventional study, meaning all participants will receive the study intervention. It plans to enroll 80 participants.
- What's involved
- You will view both very brief and visible combat stimuli during a functional magnetic brain imaging (fMRI) scan. You will also provide ratings of fear, awareness, and tolerability.
- Compensation
- Not stated in the trial record.
- Follow-up
- Brain activation will be measured at Day 2.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Bradley M Peterson, MD · PRINCIPAL_INVESTIGATOR · Children's Hospital Los Angeles
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Mean Activation of Frontostriatal and Prefrontal Brain Regions to combat stimuli in PTSDDay 2
A hypothesis-driven, group-level analysis will test brain activity, measured as Blood Oxygen Level Dependent (BOLD) response, in 4 regions of interest while minimizing Type II error.